Scott B. Ullem, CVP, Chief Financial Officer at Edwards Lifesciences Corp (EW), sold 13,000 shares at $80.50 ($1.0M) on 2026-04-09, disclosed to the SEC on 2026-04-09.
Scheduled sale ($1.0M) by CVP, Chief Financial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $79.79 | 8,324 | $664K | 63.8% |
| 2 | $80.50 | 4,676 | $376K | 36.2% |
| Total | $80.04 avg | 13,000 | $1.0M | 100% |
| Filing → |
| EW | SELL | 2025-11-10 | $2.2M | — | Filing → |
| EW | SELL | 2025-05-09 | $1.7M | — | Filing → |
| EW | SELL | 2025-03-26 | $1.6M | — | Filing → |